Patents by Inventor Joseph MABBITT

Joseph MABBITT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS FOR TUMOUR-SPECIFIC CELL DEPLETION
    Publication number: 20200283535
    Abstract: Described is a human IgG2 anti-CD25 antibody, wherein the antibody depletes CD25 cells, in particular tumour-infiltrating regulatory T cells. The antibody can be used in the treatment of cancer, for example in treating solid tumours and in haematological cancers.
    Type: Application
    Filed: July 6, 2018
    Publication date: September 10, 2020
    Applicants: Tusk Therapeutics Ltd., Cancer Research Technology Limited
    Inventors: Pascal MERCHIERS, Anne GOUBIER, Kevin MOULDER, Josephine SALIMU, Beatriz GOYENECHEA CORZO, Sergio QUEZADZ, Karl PEGGS, Frederick ARCE VARGAS, Isabelle SOLOMON, Joseph MABBITT, Stephanie HOPLEY